[In the Media] “No Time to Lose in Tackling Dementia: How Should Medicine and Big Pharma Address This Global Challenge?” (Nikkei-Gooday)
date : 11/27/2015
This article featured a conversation between Kiyoshi Kurokawa, Member of the G7 World Dementia Council, and Mr. Joji Nakayama, Representative Director, President & CEO of Daiichi Sankyo Co., Ltd.
For full article:
“No Time to Lose in Tackling Dementia: How Should Medicine and Big Pharma Address This Global Challenge?” (Nikkei-Gooday)
*Available only in Japanese.
Dementia is increasingly becoming an issue around the world. OECD and HGPI co-organized a Private Sector Side Meeting alongside the G7 Global Dementia Legacy Event organized by the Japanese Government in November 2014 in Tokyo.
For more information;
Taking Action on Dementia: Opportunities for Social Investment- A G7 Global Dementia Legacy Event Private Sector Side Meeting
HGPI followed up by submitting a policy recommendation. Later the National Strategy of Dementia was revised and released as what is called the New Orange plan in January 2015 moving dementia policy forward.
For full article:
“No Time to Lose in Tackling Dementia: How Should Medicine and Big Pharma Address This Global Challenge?” (Nikkei-Gooday)
*Available only in Japanese.
Dementia is increasingly becoming an issue around the world. OECD and HGPI co-organized a Private Sector Side Meeting alongside the G7 Global Dementia Legacy Event organized by the Japanese Government in November 2014 in Tokyo.
For more information;
Taking Action on Dementia: Opportunities for Social Investment- A G7 Global Dementia Legacy Event Private Sector Side Meeting
HGPI followed up by submitting a policy recommendation. Later the National Strategy of Dementia was revised and released as what is called the New Orange plan in January 2015 moving dementia policy forward.
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] AMR Policy Update #8: Fostering AMR-Conscious Youth: The Antibiotic Smart Sweden Certificate Program and its Implications for Early Childhood Education (July 1, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-02
[Research Report] Medical Practitioner Interviews on the Current State and Issues for Interdepartmental Collaboration in Clinical Practice for Chronic Kidney Disease (June 30, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)



